Condition

Relapsed Acute Myeloid Leukemia clinical trials and research

• 6Clinical trials
• 2Countries

Newest Relapsed Acute Myeloid Leukemia clinical trials

All recruiting trials (6)

• Imetelstat with azacitidine, with or without venetoclax, for relapsed AML

  This test adds imetelstat to azacitidine, sometimes with venetoclax, to see if it helps adults whose AML has come back or not responded to prior therapy.

  Recruiting Phase 1 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07320235

• Evaluating a new chemotherapy regimen for relapsed or refractory AML

  This study is testing a new combination of chemotherapy drugs to see if it can help people with acute myeloid leukemia that hasn't responded to other treatments.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing · NCT06741722

• Combining tagraxofusp with low-intensity chemotherapy for treating specific types of leukemia

  This study is testing a new treatment combining tagraxofusp with low-intensity chemotherapy to see if it helps people with certain types of leukemia that haven't responded to previous treatments.

  Recruiting Phase 1/2 Stanford University · Palo Alto, California · NCT06561152

• Combining PD-1 inhibitor with venetoclax for treating tough cases of leukemia and myelodysplastic syndromes

  This study is testing a new treatment that combines three drugs to see if it can help people with tough cases of leukemia and myelodysplastic syndromes who haven't responded to other treatments.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing, Beijing Municipality · NCT06536959

• Combining revumenib, azacitidine, and venetoclax for treating pediatric and young adult patients with tough cases of acute myeloid leukemia

  This study is testing a new combination of drugs to see if it can help young patients with tough cases of acute myeloid leukemia feel better and achieve remission.

  Recruiting at 10 sites Phase 1 St. Jude Children's Research Hospital · San Diego, California and 9 other locations · NCT06177067

• Using CAR T cells to treat acute myeloid leukemia

  This study is testing a new treatment using specially modified CAR T cells to see if it can safely help adults and kids with tough cases of acute myeloid leukemia.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06017258

Related topics

Quick answers

How many Relapsed Acute Myeloid Leukemia clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (4 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →